Logo image of LOVE.CA

CANNARA BIOTECH INC (LOVE.CA) Stock Fundamental Analysis

TSX-V:LOVE - TSX Venture Exchange - CA13765U2002 - Common Stock - Currency: CAD

1.74  +0.02 (+1.16%)

Fundamental Rating

4

Overall LOVE gets a fundamental rating of 4 out of 10. We evaluated LOVE against 4 industry peers in the Personal Care Products industry. LOVE has an average financial health and profitability rating. LOVE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year LOVE was profitable.
In the past year LOVE had a positive cash flow from operations.
In multiple years LOVE reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: LOVE reported negative operating cash flow in multiple years.
LOVE.CA Yearly Net Income VS EBIT VS OCF VS FCFLOVE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

1.2 Ratios

The Return On Assets of LOVE (8.30%) is better than 100.00% of its industry peers.
LOVE's Return On Equity of 14.22% is amongst the best of the industry. LOVE outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 8.3%
ROE 14.22%
ROIC N/A
ROA(3y)3.63%
ROA(5y)-2.7%
ROE(3y)6.49%
ROE(5y)-3.09%
ROIC(3y)N/A
ROIC(5y)N/A
LOVE.CA Yearly ROA, ROE, ROICLOVE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

LOVE's Profit Margin of 14.16% is amongst the best of the industry. LOVE outperforms 100.00% of its industry peers.
With a Gross Margin value of 9.96%, LOVE perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Gross Margin of LOVE has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 14.16%
GM 9.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.07%
GM growth 5Y-41.26%
LOVE.CA Yearly Profit, Operating, Gross MarginsLOVE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

5

2. Health

2.1 Basic Checks

LOVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
LOVE has less shares outstanding than it did 1 year ago.
LOVE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for LOVE has been reduced compared to a year ago.
LOVE.CA Yearly Shares OutstandingLOVE.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LOVE.CA Yearly Total Debt VS Total AssetsLOVE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 1.98 indicates that LOVE is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of LOVE (1.98) is better than 75.00% of its industry peers.
LOVE has a debt to FCF ratio of 8.39. This is a slightly negative value and a sign of low solvency as LOVE would need 8.39 years to pay back of all of its debts.
LOVE has a better Debt to FCF ratio (8.39) than 75.00% of its industry peers.
LOVE has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
LOVE has a Debt to Equity ratio of 0.43. This is amongst the best in the industry. LOVE outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 8.39
Altman-Z 1.98
ROIC/WACCN/A
WACC7.13%
LOVE.CA Yearly LT Debt VS Equity VS FCFLOVE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 2.35 indicates that LOVE has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.35, LOVE is doing good in the industry, outperforming 75.00% of the companies in the same industry.
LOVE has a Quick Ratio of 2.35. This is a bad value and indicates that LOVE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.93, LOVE is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 0.93
LOVE.CA Yearly Current Assets VS Current LiabilitesLOVE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

4

3. Growth

3.1 Past

LOVE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 110.22%, which is quite impressive.
LOVE shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.97%.
Measured over the past years, LOVE shows a very strong growth in Revenue. The Revenue has been growing by 108.26% on average per year.
EPS 1Y (TTM)110.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%193.73%
Revenue 1Y (TTM)28.97%
Revenue growth 3Y68.19%
Revenue growth 5Y108.26%
Sales Q2Q%35.07%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LOVE.CA Yearly Revenue VS EstimatesLOVE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.60, the valuation of LOVE can be described as reasonable.
100.00% of the companies in the same industry are more expensive than LOVE, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of LOVE to the average of the S&P500 Index (27.50), we can say LOVE is valued rather cheaply.
Industry RankSector Rank
PE 11.6
Fwd PE N/A
LOVE.CA Price Earnings VS Forward Price EarningsLOVE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of LOVE indicates a somewhat cheap valuation: LOVE is cheaper than 75.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 27.33
EV/EBITDA N/A
LOVE.CA Per share dataLOVE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LOVE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANNARA BIOTECH INC

TSX-V:LOVE (7/18/2025, 7:00:00 PM)

1.74

+0.02 (+1.16%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)04-28 2025-04-28
Earnings (Next)07-28 2025-07-28
Inst Owners0.13%
Inst Owner ChangeN/A
Ins Owners27.72%
Ins Owner ChangeN/A
Market Cap159.09M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.6
Fwd PE N/A
P/S 1.68
P/FCF 27.33
P/OCF 14.11
P/B 1.69
P/tB 1.69
EV/EBITDA N/A
EPS(TTM)0.15
EY8.62%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.06
FCFY3.66%
OCF(TTM)0.12
OCFY7.09%
SpS1.04
BVpS1.03
TBVpS1.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.3%
ROE 14.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 14.16%
GM 9.96%
FCFM 6.15%
ROA(3y)3.63%
ROA(5y)-2.7%
ROE(3y)6.49%
ROE(5y)-3.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.07%
GM growth 5Y-41.26%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 8.39
Debt/EBITDA N/A
Cap/Depr 84.34%
Cap/Sales 5.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 43.44%
Current Ratio 2.35
Quick Ratio 0.93
Altman-Z 1.98
F-Score5
WACC7.13%
ROIC/WACCN/A
Cap/Depr(3y)228.25%
Cap/Depr(5y)410.31%
Cap/Sales(3y)22.24%
Cap/Sales(5y)120%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)110.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%193.73%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)28.97%
Revenue growth 3Y68.19%
Revenue growth 5Y108.26%
Sales Q2Q%35.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y132.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y334.7%
OCF growth 3YN/A
OCF growth 5YN/A